em. prof. dr. Guy Joos
- ORCID iD
- 0000-0002-3149-9444
Show
Sort by
-
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability‑Adjusted Life‑Years Within the International Respiratory Coalition’s Lung Facts
-
- Journal Article
- A1
- open access
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
-
NO in de uitgeademde lucht, een overzicht
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry
-
- Journal Article
- A1
- open access
ERS statement : a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
-
An unexpected cause of constipation and abdominal distension in COPD
-
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
-
MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation
-
- Miscellaneous
- open access
Digital Health Europe (DHE) twinning on severe asthma : kick-off meeting report
-
- Journal Article
- A1
- open access
Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease